Drugs that have sought FDA approval for the specific indication of diabetic neuropathic pain naturally will have more studies (and evidence) because of the FDA's requirements. The sheer number of trials is not indicative of an agent's place in therapy, however. Nevertheless, based on this spe...
The scope of the present review is to describe epidemiology, classification, symptomatology and treatment of diabetic peripheral somatic neuropathy and autonomic neuropathy. Special attention is paid to the use of local anaesthetic agents in painful diabetic neuropathy. Denervation hypersensitivity is a char...
Severaltypes of stem cellsare being explored for neuropathy treatment, including bone marrow-derived stem cells, adipose-derived stem cells, and induced pluripotent stem cells. The choice of stem cell type and administration method can vary depending on the specific needs of the patient and the und...
Despite the number of patients affected by diabetic peripheral neuropathic pain (DPNP), little consensus exists about the pathophysiology, best diagnostic tools, and primary treatment choices. Theories about the causes of DPNP are inextricably linked with the causes of diabetic neuropathies, yet most pa...
Objective: To assess the efficacy and tolerability of acetyl-L-carnitine (levacecarnine; LAC) versus placebo in the treatment of diabetic neuropathy, mainly by evaluating the effects of treatment on electrophysiological parameters and pain symptoms. Design: This was a multicentre (n = 20), randomi...
To assess the effect of high-dose vitamin D in patients with painful diabetic neuropathy.A single intramuscular dose of 600 000 IU vitamin D was administered, and the effects on metabolic parameters and neuropathic pain assessed over 20 weeks.143 participants with predominantly type 2 diabete...
Clinical features, diagnosis, and treatment of diabetic neuropathyZiegler, D
Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy. Diabetic neuropathy is one of the most common long-term complications in patients with diabetes mellitus, with a prevalence of 60鈥 70% in the United States... MA Ramirez,NL Borja - 《Pharmacotherapy》 被引量: ...
Processing of foot pressure images and display of an advanced clinical parameter PR in Diabetic Neuropathy In diabetic foot, sensation loss predisposes to skin ulceration which may result in amputation, the most feared complication. Therefore, understanding and ... S.R. Shah,K.M. Patil - Intern...
nosis and Treatment Diabetic Neuropathy: Early Diagnosis and TreatmentDiabetic Neuropathy: Early Diagnosis and TreatmentStracke, H.Federlin, K.ZEITSCHRIFT FUR DIE GESAMTE INNERE MEDIZIN UND IHRE GRENZGEBIETE